MD Anderson Opts for Stone Bond LIMS for New siRNA Facility

Jul 01, 2008

NEW YORK (GenomeWeb) – LIMS provider Stone Bond Technologies said today that MD Anderson Cancer Center has selected its EE-LIMS system to manage data for its newly established siRNA facility.

MD Anderson will use the LIMS to document laboratory workflow activities and automate operations management in the siRNA laboratory.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

An RNAi Approval

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Keep It Going

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Stop It There

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

This Week in PLOS

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Main menu